Alphasimplex Group, LLC Bristol Myers Squibb CO Transaction History

Alphasimplex Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $215,241 - $258,093	-3,501 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $341,623 - $398,252	-6,370 Reduced 64.53%	3,501 $218,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $135,203 - $158,373	-2,285 Reduced 18.8%	9,871 $584,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $215,023 - $243,661	-3,724 Reduced 23.45%	12,156 $754,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $911,988 - $1.01 Million	15,880 New	15,880 $957,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Alphasimplex Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Alphasimplex Group, LLC with notifications on news.